FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Neil Poulter

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Case Control Studies

Co-author Network

Publications

TOP 3
Peter S Sever; Andrew Whitehouse; Choon L Chang; Ajay Gupta; Neil R Poulter; Margaret F Prescott; Michael Scanlon
Is plasma renin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients? Observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Neil R Poulter; Nishi Chaturvedi
Commentary: Shaper and Jones, 'serum-cholesterol, diet and coronary heart-disease in Africans and Asians in Uganda': 50-year-old findings only need interpretational fine tuning to come up to speed!
Peter S Sever; Simon A McG Thom; Paul Welsh; Choon L Chang; Aroon Hingorani; Alun D Hughes; Neil R Poulter; Naveed Sattar
Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Neil Poulter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Peter S Sever; Andrew Whitehouse; Choon L Chang; Ajay Gupta; Neil R Poulter; Margaret F Prescott; Michael Scanlon
Is plasma renin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients? Observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
European heart journal 2012;33(23):2970-9.
2012: Neil R Poulter; Nishi Chaturvedi
Commentary: Shaper and Jones, 'serum-cholesterol, diet and coronary heart-disease in Africans and Asians in Uganda': 50-year-old findings only need interpretational fine tuning to come up to speed!
International journal of epidemiology 2012;41(5):1228-30.
2012: Peter S Sever; Simon A McG Thom; Paul Welsh; Choon L Chang; Aroon Hingorani; Alun D Hughes; Neil R Poulter; Naveed Sattar
Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial.
European heart journal 2012;33(4):486-94.
2011: Ajay K Gupta; Efthimia G Nasothimiou; Neil R Poulter; Peter S Sever; Choon L Chang; Bjorn Dahlöf
Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk.
Journal of hypertension 2011;29(10):2004-13.
2011: Peter S Sever; Andrew Whitehouse; Choon L Chang; Ajay K Gupta; Neil R Poulter
The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the U.K.
European heart journal 2011;32(20):2525-32.
2011: Neil R Poulter
Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: an estimate from population studies.
Journal of hypertension 2011;29(7):1281-2.
2011: David J Collier; Neil R Poulter; Björn Dahlöf; Peter S Sever; Hans Wedel; Jan Buch; Mark J Caulfield
Impact of amlodipine-based therapy among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).
Journal of hypertension 2011;29(3):583-91.
2011: David J Collier; Neil R Poulter; Björn Dahlöf; Peter S Sever; Hans Wedel; Jan Buch; Mark J Caulfield
Impact of atorvastatin among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial Lipid-Lowering Arm.
Journal of hypertension 2011;29(3):592-9.
2011: Neil Chapman; Björn Dahlöf; Gene Feder; Mark Caulfield; Choon-Lan Chang; Peter S Sever; Neil R Poulter
Ethnic variations in lipid-lowering in response to a statin (EVIREST): a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Ethnicity & disease 2011;21(2):150-7.
2010: Ajay K Gupta; Neil R Poulter; Joanna Dobson; Sandra Eldridge; Francesco P Cappuccio; Mark Caulfield; David Collier; J Kennedy Cruickshank; Peter S Sever; Gene Feder
Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial.
American journal of hypertension 2010;23(9):1023-30.
2010: Ajay K Gupta; Bjorn Dahlof; Peter S Sever; Neil R Poulter
Metabolic syndrome, independent of its components, is a risk factor for stroke and death but not for coronary heart disease among hypertensive patients in the ASCOT-BPLA.
Diabetes care 2010;33(7):1647-51.
2010: Andrew S P Sharp; Robyn J Tapp; Simon A McG Thom; Darrel P Francis; Alun D Hughes; Alice V Stanton; Andrew Zambanini; Eoin O'Brien; Nish Chaturvedi; Simon Lyons; Sheila Byrd; Neil R Poulter; Peter S Sever; Jamil Mayet
Tissue Doppler E/E' ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy.
European heart journal 2010;31(6):747-52.
2010: Ajay K Gupta; Shazia Arshad; Neil R Poulter
Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis.
Hypertension 2010;55(2):399-407.
2009: Neil R Poulter; Joanna E Dobson; Peter S Sever; Björn Dahlöf; Hans Wedel; Norm R C Campbell
Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).
Journal of the American College of Cardiology 2009;54(13):1154-61.
2009: Peter S Sever; Neil R Poulter; Stylianos E Mastorantonakis; Choon-Lan Chang; Bjorn Dahlof; Hans Wedel
Coronary heart disease benefits from blood pressure and lipid-lowering.
International journal of cardiology 2009;135(2):218-22.
2009: Neil R Poulter
Blood pressure and glucose control in subjects with diabetes: new analyses from ADVANCE.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2009;27(1):S3-8.
2009: Peter S Sever; Neil R Poulter; Bjorn Dahlof; Hans Wedel
Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
Journal of hypertension 2009;27(5):947-54.
2008: Andrew Sharp; Robyn Tapp; Darrel P Francis; Simon A McG Thom; Alun HUGHES; Alice V Stanton; Andrew Zambanini; Nish Chaturvedi; Sheila Byrd; Neil R Poulter; Peter S Sever; Jamil Mayet
Ethnicity and left ventricular diastolic function in hypertension an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy.
Journal of the American College of Cardiology 2008;52(12):1015-21.
2008: Neil Chapman; Choon-Lan Chang; Björn Dahlöf; Peter S Sever; Hans Wedel; Neil R Poulter
Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial.
Circulation 2008;118(1):42-8.
2008: Ajay K Gupta; Bjorn Dahlof; Joanna Dobson; Peter S Sever; Hans Wedel; Neil R Poulter
Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication.
Diabetes care 2008;31(5):982-8.
2008: Peter S Sever; Neil R Poulter; Bjorn Dahlof; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku S Nieminen; Eoin T O'Brien; Jan Ostergren
The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure.
European heart journal 2008;29(4):499-508.
2007: Neil Chapman; Joanna Dobson; Sarah Wilson; Björn Dahlöf; Peter S Sever; Hans Wedel; Neil R Poulter
Effect of spironolactone on blood pressure in subjects with resistant hypertension.
Hypertension 2007;49(4):839-45.
2006: Sarah L Wilson; Neil R Poulter
The effect of non-steroidal anti-inflammatory drugs and other commonly used non-narcotic analgesics on blood pressure level in adults.
Journal of hypertension 2006;24(8):1457-69.
2006: Peter S Sever; Neil R Poulter; William J Elliott; M Charlotte Jonsson; Henry R Black; Peter S Sever; Neil R Poulter; William J Elliott; M Charlotte Jonsson; Henry R Black
Blood pressure reduction is not the only determinant of outcome.
Circulation 2006;113(23):2754-72; discussion 2773-4.
2005: Neil R Poulter; Hans Wedel; Björn Dahlöf; Peter S Sever; D Gareth Beevers; Mark Caulfield; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren; Stuart Pocock
Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).
Lancet 2005;366(9489):907-13.
2005: Björn Dahlöf; Peter S Sever; Neil R Poulter; Hans Wedel; D Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
Lancet 2005;366(9489):895-906.
2005: Peter S Sever; Neil R Poulter; Björn Dahlöf; Hans Wedel
Different time course for prevention of coronary and stroke events by atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA).
The American journal of cardiology 2005;96(5A):39F-44F.
2005: Peter S Sever; Neil R Poulter; Björn Dahlöf; Hans Wedel; Rory Collins; Gareth Beevers; Mark Caulfield; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).
Diabetes care 2005;28(5):1151-7.
2004: Neil R Poulter
Modulating the design of clinical trials to address the question of mechanisms of disease.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2004;26(7-8):727-30.
2004: Neil R Poulter
Measures of global risk: old versus new methods.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2004;26(7-8):653-62.
2004: Peter S Sever; Björn Dahlöf; Neil R Poulter; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
Drugs 2004;64 Suppl 2():43-60.
2003: Peter S Sever; Björn Dahlöf; Neil R Poulter; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
Lancet 2003;361(9364):1149-58.
2003: Sarah Wilson; Atholl Johnston; John Robson; Neil R Poulter; David J Collier; Gene Feder; Mark J Caulfield
Predicting coronary risk in the general population--is it necessary to measure high-density lipoprotein cholesterol?
Journal of cardiovascular risk 2003;10(2):137-41.
2002: Choon-Lan Chang; Martin J Shipley; Michael Marmot; Neil R Poulter
Can cardiovascular risk factors explain the association between education and cardiovascular disease in young women?
Journal of clinical epidemiology 2002;55(8):749-55.
2002: Choon-Lan Chang; Michael Marmot; Timothy M M Farley; Neil R Poulter
The influence of economic development on the association between education and the risk of acute myocardial infarction and stroke.
Journal of clinical epidemiology 2002;55(8):741-7.
2001: Alice V Stanton; JN Chapman; Jamil Mayet; Peter S Sever; Neil R Poulter; Alun HUGHES; Simon A McG Thom
Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery.
Clinical science (London, England : 1979) 2001;101(5):455-64.
2001: Neil R Poulter; Mark Caulfield; Gene Feder
Ethnic variations in response to a statin (EVIREST).
Journal of human hypertension 2001;15 Suppl 1():S87-9.
2001: P L Kirby; M C Caulfield; David J Collier; Sandra Eldridge; C G Griffiths; Harry Hemingway; Neil R Poulter; Gene Feder
Differential response to amlodipine and atenolol mono-therapy for hypertension by ethnic group.
Journal of human hypertension 2001;15 Suppl 1():S61-4.
2001: JN Chapman; P Kirby; M C Caulfield; Neil R Poulter
Cardiovascular risk factors in a cohort of 30,000 high-risk men and women in the UK: cross-sectional, retrospective and prospective studies of screenees for the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Journal of human hypertension 2001;15 Suppl 1():S23-6.
2001: Peter S Sever; Björn Dahlöf; Neil R Poulter; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol.
Journal of human hypertension 2001;15 Suppl 1():S11-2.
2001: Neil R Poulter
Birthweights, maternal cardiovascular events, and Barker hypothesis.
Lancet 2001;357(9273):1990-1.
2001: Peter S Sever; Björn Dahlöf; Neil R Poulter; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators.
Journal of hypertension 2001;19(6):1139-47.
2001: Neil Chapman; Jamil Mayet; MA Ozkor; F C Lampe; Simon A McG Thom; Neil R Poulter
QT intervals and QT dispersion as measures of left ventricular hypertrophy in an unselected hypertensive population.
American journal of hypertension 2001;14(5 Pt 1):455-62.
2001: S L Wilson; Neil R Poulter
Cardiovascular risk: its assessment in clinical practice.
British journal of biomedical science 2001;58(4):248-51.
2000: Jamil Mayet; Ben Ariff; Balvinder Wasan; Neil Chapman; Manjit Shahi; Neil R Poulter; Peter S Sever; Rodney A Foale; Simon A McG Thom
Improvement in midwall myocardial shortening with regression of left ventricular hypertrophy.
Hypertension 2000;36(5):755-9.
2000: Peter S Sever; Neil R Poulter
Hypertension drug trials: past, present, and future.
Journal of human hypertension 2000;14(10-11):729-38.
2000: Neil R Poulter
Benefits and pitfalls of cardiovascular risk assessment.
Journal of human hypertension 2000;14 Suppl 2():S11-6.
2000: Neil R Poulter
Risk of fatal pulmonary embolism with oral contraceptives.
Lancet 2000;355(9221):2088.
2000: Stefano Guzzetti; Jamil Mayet; Manjit Shahi; Silvia Mezzetti; Rodney A Foale; Peter S Sever; Neil R Poulter; Alberto Porta; Alberto Malliani; Simon A McG Thom
Absence of sympathetic overactivity in Afro-Caribbean hypertensive subjects studied by heart rate variability.
Journal of human hypertension 2000;14(5):337-42.
2000: JN Chapman; A T French; Neil R Poulter; Peter S Sever
Page's syndrome: a case of pseudophaeochromocytoma.
Journal of human hypertension 2000;14(2):149-50.
1999: Neil R Poulter; CL Chang; Timothy M M Farley; Olav Meirik
Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications.
Lancet 1999;354(9190):1610.
1999: Neil R Poulter; CL Chang; Timothy M M Farley; Michael Marmot; Olav Meirik
Effect on stroke of different progestagens in low oestrogen dose oral contraceptives. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Lancet 1999;354(9175):301-2.
1999: JN Chapman; Jamil Mayet; C L Chang; Rodney A Foale; Simon A McG Thom; Neil R Poulter
Ethnic differences in the identification of left ventricular hypertrophy in the hypertensive patient.
American journal of hypertension 1999;12(5):437-42.
1999: Jamil Mayet; P Kanagaratnam; Manjit Shahi; Roxy Senior; M Doherty; Neil R Poulter; Peter S Sever; C E Handler; Simon A McG Thom; Rodney A Foale
QT dispersion in athletic left ventricular hypertrophy.
American heart journal 1999;137(4 Pt 1):678-81.
1998: Timothy M M Farley; Olav Meirik; CL Chang; Neil R Poulter
Combined oral contraceptives, smoking, and cardiovascular risk.
Journal of epidemiology and community health 1998;52(12):775-85.
1998: Neil R Poulter
Calcium antagonists and the diabetic patient: a response to recent controversies.
The American journal of cardiology 1998;82(9B):40R-41R.
1998: Jamil Mayet; Neil Chapman; C K Li; Manjit Shahi; Neil R Poulter; Peter S Sever; Rodney A Foale; Simon A McG Thom
Ethnic differences in the hypertensive heart and 24-hour blood pressure profile.
Hypertension 1998;31(5):1190-4.
1998: Timothy M M Farley; Olav Meirik; Michael Marmot; CL Chang; Neil R Poulter
Oral contraceptives and risk of venous thromboembolism: impact of duration of use.
Contraception 1998;57(1):61-5.
1997: Jamil Mayet; K P O'Kane; R Elton; H A Johnstone; Manjit Shahi; MA Ozkor; Alice V Stanton; Neil R Poulter; Peter S Sever; Rodney A Foale; D J Webb; Simon A McG Thom
Left ventricular hypertrophy, blood pressure and ACE genotype in untreated hypertension.
Journal of human hypertension 1997;11(9):595-7.
1997: Jamil Mayet; Manjit Shahi; Neil R Poulter; Peter S Sever; Rodney A Foale; Simon A McG Thom
Left ventricular geometry in presenting untreated hypertension.
Journal of human hypertension 1997;11(9):593-4.
1997: Jamil Mayet; Neil Chapman; Manjit Shahi; Neil R Poulter; D A Cunningham; S Dave; Jaspal S Kooner; Peter S Sever; Rodney A Foale; Simon A McG Thom
The effects on cardiac arrhythmias of antihypertensive therapy causing regression of left ventricular hypertrophy.
American journal of hypertension 1997;10(6):611-8.
1997: Neil R Poulter; CL Chang; Michael Marmot; Timothy M M Farley; Olav Meirik
Third-generation oral contraceptives and venous thrombosis.
Lancet 1997;349(9053):732.